Abstract
This study aimed to explore suitable clustering algorithms for author collaborations (ACs) in bibliometrics and investigate which countries frequently coauthored with others in recent years. To achieve this, the study developed a method called the Follower-Leading Clustering Algorithm (FLCA) and used it to analyze ACs and cowords in the Journal of Medicine (Baltimore) from 2020 to 2022. This study extracted article metadata from the Web of Science and used the statistical software R to implement FLCA, enabling efficient and reproducible analysis of ACs and cowords in bibliometrics. To determine the countries that easily coauthored with other countries, the study observed the top 20 countries each year and visualized the results using network charts, heatmaps with dendrograms, and Venn diagrams. The study also used chord diagrams to demonstrate the use of FLCA on ACs and cowords in Medicine (Baltimore). The study observed 12,793 articles, including 5081, 4418, and 3294 in 2020, 2021, and 2022, respectively. The results showed that the FLCA algorithm can accurately identify clusters in bibliometrics, and the USA, China, South Korea, Japan, and Spain were the top 5 countries that commonly coauthored with others during 2020 and 2022. Furthermore, the study identified China, Sichuan University, and diagnosis as the leading entities in countries, institutes, and keywords based on ACs and cowords, respectively. The study highlights the advantages of using cluster analysis and visual displays to analyze ACs in Medicine (Baltimore) and their potential application to coword analysis. The proposed FLCA algorithm provides researchers with a comprehensive means to explore and understand the intricate connections between authors or keywords. Therefore, the study recommends the use of FLCA and visualizations with R for future research on ACs with cluster analysis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.